Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,807,060
-
Share change
-
+372,444
-
Total reported value
-
$7,893,000
-
Put/Call ratio
-
47%
-
Price per share
-
$1.64
-
Number of holders
-
26
-
Value change
-
+$553,068
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2021
As of 30 Jun 2021,
IGC Pharma, Inc. - COM NEW (IGC) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,807,060 shares.
The largest 10 holders included
Davy Global Fund Management Ltd, BlackRock Inc., VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, and DEARBORN PARTNERS LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.